An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 9, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions

Ulcerative Colitis

Trial Locations (3)

RECRUITING

The Second Affiliated Hospital Of Zhengzhou University /ID# 274754, Zhengzhou

RECRUITING

The First Affiliated Hospital, Sun-Yat Sen University /ID# 272997, Guangzhou

RECRUITING

The Sixth Affiliated Hospital of Sun Yat-sen University /ID# 274753, Guangzhou